GC
IMVT icon

Guggenheim Capital’s Immunovant IMVT Stock Holding History

Guggenheim Capital’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
12,382
+122
+1% +$3.16K ﹤0.01% 1374
2025
Q4 		$312K Sell
12,260
-27,185
-69% -$606K ﹤0.01% 1508
2025
Q3 		$636K Sell
39,445
-2,056
-5% -$33.3K ﹤0.01% 1088
2025
Q2 		$664K Sell
41,501
-471
-1% -$7.12K 0.01% 1045
2025
Q1 		$717K Buy
41,972
+5,055
+14% +$106K 0.01% 1032
2024
Q4 		$914K Buy
36,917
+188
+0.5% +$5.33K 0.01% 956
2024
Q3 		$1.05M Sell
36,729
-809
-2% -$23.9K 0.01% 1077
2024
Q2 		$991K Buy
37,538
+3,311
+10% +$94.2K 0.01% 1121
2024
Q1 		$1.11M Buy
34,227
+6,352
+23% +$232K 0.01% 1142
2023
Q4 		$1.17M Buy
+27,875
New +$1.03M 0.01% 1071

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return